Ходжкинге жатпайтын лимфоманың емдеу — Lu Daopei Hematology Hospital

Beijing Lu Daopei Hospital is a specialized hematology hospital in Beijing, founded in 2001. The hospital has a built-up area of 29,000 square meters, 1,300 beds and a team of 350 doctors, and comprises 30 departments, including the Hematopoietic Stem Cell Transplantation Department, the General Hematology Department, the Lymphoma, Myeloma and Leukemia Centers, the Department of Pathology, medical laboratories and others. The hospital treats around 200,000 patients a year.

Key Doctors

• Professor Peihua Lu — Chairman of the Hematology Committee of the Chinese Association of Medical Institutions and an American expert in hematology and oncology.
• Dr. Mingang Lu — leads projects for the National Natural Science Foundation of China.

The hospital's medical team also includes other national and international experts.

Specialized Centers and Departments

• Lymphoma, Myeloma and Leukemia Centers: provide patients with precise clinical diagnosis and disease assessment, promptly determine drug concentration, adverse drug reactions and minimal residual disease during treatment, and adjust treatment strategies and plans to maximize the chance of cure.
• Department of Pediatric Hematology: diagnoses and treats blood system diseases and tumors in children, including anemia of various causes, hemorrhagic diseases, leukopenia, hemophagocytic syndrome, leukemia, aplastic anemia and solid tumors in children.
• Department of Pathology and Laboratory Medicine: divided into zones for cell morphology, immunotyping, clinical pharmacology, pathology and pathogenic microorganisms; the laboratories work in close coordination and provide MICM test reports to frontline physicians promptly, supporting accurate and timely diagnosis and treatment.

Transplantation Volume

The number of allogeneic hematopoietic stem cell transplants performed at the hospital each year accounts for 10% of the national total. In 2024, a total of 1,500 hematopoietic stem cell transplants were performed nationwide, of which 438 were performed at Beijing Lu Daopei Hospital.

Technology and Outcomes

Drawing on clinical experience and the use of new, advanced equipment, the hospital combines standardized digital information systems, comprehensive medical equipment, an international care environment and a professional team to provide services to patients with blood disorders. Through research into the genetic characteristics of blood diseases, the hospital has introduced immunotherapy and targeted therapy technologies, achieved improvements recognized in fields such as EBMT and ISLH, and received awards, contributing to higher cure rates and long-term survival for patients. The hospital continues to develop new technologies and projects and to introduce advanced medical equipment to support the diagnosis and treatment of blood diseases.